Abstract
The cardiovascular morbidity and mortality are increased in rheumatoid arthritis and probably equal those of patients with type 2 diabetes mellitus. The European League Against Rheumatism has recently provided evidence-based guidelines for cardiovascular risk management in patients with rheumatoid arthritis and we here briefly summarise these guidelines and other recent data in this area of research.
Translated title of the contribution | [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis] |
---|---|
Original language | Danish |
Journal | Ugeskrift for Laeger |
Volume | 173 |
Issue number | 5 |
Pages (from-to) | 343-6 |
Number of pages | 4 |
Publication status | Published - 31 Jan 2011 |